Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases

Fig. 3

Antibodies against carbamylated proteins (anti-CarP) in serum from patients and controls. Horizontal line corresponds to cutoff value: *p < 0.0005 for rheumatoid arthritis (RA) vs normal healthy subjects (NHS) and patients with osteoporosis (OP); **p = 0.03 for RA vs systemic lupus erythematosus (SLE); ***p = 0.04 for RA vs Sjögren syndrome (SS); ****p = 0.004 RA vs systemic sclerosis (SSc); § p = 0.00001 for SLE vs NHS; §§ p = 0.002 for SLE vs SSc; §§§ p = 0.05 for SLE vs OP; # p = 0.00001 for SS vs NHS and SS vs SSc; p = 0.03 for SSc vs NHS; †† p = 0.004 for SSc vs OP

Back to article page